Investigating how certain proteins affect bone health in cells
HIFs in osteocytes
This study is looking at how certain proteins in bone cells might help improve bone growth and health, especially for people with osteoporosis, by experimenting with genes in mice and humans who have strong bones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10745325 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of hypoxia-inducible factors (HIFs) in osteocytes, which are specialized bone cells. By studying mice and humans with high bone mass, the researchers aim to uncover new mechanisms that could promote bone growth and health, particularly in conditions like osteoporosis. The approach involves manipulating specific genes to observe changes in bone structure and function, potentially leading to innovative therapies for bone loss. The findings could reveal how different signaling pathways in bone cells can be targeted to enhance bone density and strength.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk of osteoporosis or those experiencing significant bone loss, particularly post-menopausal women.
Not a fit: Patients with stable bone density and no history of bone-related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively increase bone mass and prevent fractures in patients with osteoporosis.
How similar studies have performed: Previous research has shown promising results in manipulating bone cell signaling pathways, indicating that this approach could lead to significant advancements in bone health treatments.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Yellowley-Genetos, Clare E — University of California at Davis
- Study coordinator: Yellowley-Genetos, Clare E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.